1. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid;Yuhas;Cancer Res,1980
2. Phase I trials of WR2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinum;Kligerman;Cancer Clin Trials,1981
3. Phase I trials of WR-2721 and cis-platinum;Glover;Int J Radiat Oncol Biol Phys,1984
4. WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma;Glover;J Clin Oncol,1987
5. Phase I controlled trials of WR-2721 and cyclophosphamide;Glick;Int J Radiat Oncol Biol Phys,1984